Year: 2014
Type: conference-abstract
Abstract: Bipolar affective disorder is a mood disorder with different presentation at different phase of the illness.There is no universally agreed protocol in the treatment of this disorder.Instead there are different treatment guidelines and recommendations proposed by different organizations, e.g. the CANMAT and WFSBP guidelines.The pattern of drug use may be different from place to place.This study looks at the pattern of drug treatment in the treatment of this disorder in the psychiatric outpatients clinic in 2 public hospitals and in 2 private GP's clinic.The prescription data of 1,326 patients attended the clinics in the year 2012 was reviewed.The preliminary finding is that about 78% of the patients are receiving either Lithium or other mood stabilizers (MS).Valproate is the most commonly prescribed MS, followed by Lithium.About 6% of the patients are taking a combination of both Lithium & Valproate.About half of the patients are given a second generation antipsychotic (SGA).Among the SGAs, Quetiapine is the most commonly prescribed drug (23%) followed by Risperidone (12%) and Olanzepine (10%).21% of patient are taking antidepressant drugs (AD).The majority of patients who are taking AD are also taking either MS or SGA.This study shows that mood stabilizers is the mainstay of drug treatment in bipolar affective disorder in Hong Kong.Second generation antipsychotic drugs are also commonly prescribed.Furthermore, polypharmacy is common.
Source: Bipolar Disorders
DOI: 10.1111/bdi.12186
Institutions: Aalborg University Hospital, Aalborg University
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,730
OpenAlex ID: W2113898913